The role of metalloproteinases in kidney pathophysiology;Rola metaloproteinaz w patofizjologii nerek

Polski Merkuriusz Lekarski

Volumn 19, Issue 114, 2005, Pages 812-815

  Rysz, Jacek ^a,c   Pȩdzik, Adrianna ^a   Markuszewski, Leszek ^a   Kujawski, Krzysztof ^a   Błaszczak, Robert ^a   Olszewski, Robert ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b INSTITUTE OF CARDIOLOGY   (Poland)

^c WAM ^*  (Poland)

Author keywords

Chronic kidney failure; Extracellular matrix; Metalloproteinases

Indexed keywords

ELASTASE; GELATINASE; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; LYSINE DERIVATIVE; MATRIX METALLOPROTEINASE; METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

CELL METABOLISM; CHRONIC KIDNEY DISEASE; DEGRADATION; EXTRACELLULAR MATRIX; METABOLIC REGULATION; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; TISSUE REGENERATION;

EXTRACELLULAR MATRIX; HUMANS; KIDNEY FAILURE, CHRONIC; METALLOPROTEASES;

EID: 30644462902     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Arthur M.J.: Collagenase and liver fibrosis. J. Hepatol., 1995, 22, 43-48;
2. Bailey C.J., Hembry R.M., Alexander A.: Distribution of matrix metaloproteinases stomelysin, gelatinase A and B, and collagenase in Crons disease and normal intestines. J. Clin. Pathol., 1994, 47, 113-117;
3. Daisuke S.: Metalloproteinase in the pathogenesis of diabetic nephropaty. Nephron., 1998, 80, 125-133;
4. Danne T., Spiro M.J., Spiro R.G.: Effect of high glucose on type IV collagen production by cultured glomerular epithelial, endothelial and mesangial cells. Diabetes, 1993, 42, 170-177;
5. Dollery C.M., McEwan J.R., Henney A.M.: Matrix metalloproteinases and cardiovascular diseases. Circ. Res., 1995, 77, 863-868.
6. Ebihara I., Nakamura T.: Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin dependent diabetes mellitus. Am. J. Kidney. Dis., 1998, 32, 544-550;
7. Ebihara I., Nakamura T., Norlaki S., et al.: Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin dependent diabetes mellitus. Am. J. Kidney Dis., 1998, 32, 544-550;
8. Eddy A.A., Kim H., Lopez-Guisa J., et al.: Interstitial fibrosis in mice with overloand proteinuria: deficiency of TIMP-1 is not protective. Kidney Int., 2000, 58, 618-628.
9. Gambaro G., Barmanti M., Marchi M. et al.: Therapy with glycosaminoglycans in nephrology. Fourth Symposium on Glycosaminoglycans, 1995.
10. Giannelli G., Falk-Marzillier J., Schiraldi O., et al.: Induction of cell migration by matrix metalloproteinase-2 cleavage of laminin-5. Science, 1997, 277, 225-228.
11. Gomez D.E., Alonso D.F., Yoshiji H., et al.: Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell. Biol., 1997, 74, 111-122.
12. Guedez L., Stetler-Stevenson W.G., Wolff L., et al.: In vitro suppresion of programmed cell death of B cells by tissue inhibitor of metalloproteinase-1. J. Clin. Invest., 1998, 102, 2002-2010.
13. Itoh T., Ikeda T., Gomi H., et al.: Unaltered secretion of beta-amyloid precursor protein in gelatinase A(matrix metalloproteinase 2)-deficient mice. J. BiOl. Chem., 1997, 272, 22389-22392.
14. Kanwar Y.S., Ota K., Yang Q., et al.: Rote of membrane-type matrix metalloproteinase1, MMP-2, and its inhibitor in nephrogenesis. Am. J. Physiol., 1999, 277, 934-947.
15. Kolben M., Lopens A., Blaser J.: Proteases and their inhibitors are indicative of gestational age. Eur. J. Obstet. Gynaecol., 1996, 68, 59-65.
16. Lelongt B., Legallicier B., et al.: Do matrix gelatinases play a role in renal development, physiology and glomerular diseases? Current Opinion in Nephrology, 2001, 10, 7-12;
17. Lenz O., Elliot S.J., Stetler-Stevenson W.G.: Matrix metalloproteinases in renal development and disease. J. Am. Soc. Nephrol., 2000, 11, 574-581;
18. Leppert D., Ford J., Stabler G.: Matrix metalloproteinase-9 is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. Brain, 1998, 121, 2327-2334;
19. Lijnen H.R., Silence J., Lemmens G., et al.: Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system. Thromb. Haemost., 1998, 79, 1171-1176.
20. Liu Z., Shipley J.M., Vu T.H., et al.: Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J. Exp. Med., 1998, 188, 475-482.
21. Lovett D.H., Sterzel R.B., Kashgarian R.B. et al.: Neutral proteinase activity produced in vitro by cells of the glomerular mesangium. Kidney Int., 1983, 23, 342-349.
22. McMillan J.I., Riordan J.W., Couser W.G., et al.: Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy. J Clin Invest., 1996, 97, 1094-1101.
23. Sato H., Takino T., Okada Y. Et al.: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature, 1994, 370, 61-65.
24. Steinmann-Niggil K., Ziswiler R., Kung M. et al.: Inhibition of matrix metalloproteinases attenuates anti-Thy 1.1 nephritis. J. Am. Soc. Nephrol., 1998, 9, 397-407;
25. Tanney D.C., Feng G., Pollock A.S. et al.: Regulated exrpession of matrix metalloproteinases and TIMP in nephrogenesis. Dev. Dyn., 1998, 213, 121-129.
26. Turck J., Pollock A.S., Lee L.K., et al.: Matrix metalloproteinase-2 regulates gromerular mesangial cell proliferation and differentiation. J. Biol. Chem., 1996, 271, 15074-15083.
27. Vu T.H., Werb Z. Gelatinase B.: Structure regulation and function. In: Matrix metalloproteinases. Parks W.C., Mercham R.P. (editors). San Diego: Academic Press, 1998, 115-140.
28. Wang M., Qin X., Mudgett J.S., et al.: Matrix metalloproteinase deficiencies affect contact hypersensitivity: stomelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. Proc. Natl. Acad. Sci., USA, 1999, 96, 6885-6889;
29. Westermarck J., Kahari V.M.: Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J., 1999, 13, 781-792.
30. Yee J.: Plasma matrix metalloproteinase-9 and diabetic microalbuminuria: tip of the iceberg. Am. J. Kidney Dis., 1998, 32, 659-671.